secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2023-05-09T23:59:59+00:00
Accession:  0001411690-23-000022
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Q1 revenue $7.4M (+30% YoY); announces ~$20M cost reduction plan including layoffs
--------------------------------------------------------------------------------

- GAAP gross margin improved to 28% from 15% YoY; non-GAAP gross margin 30%.
- GAAP operating expense $39.9M; cash, equivalents and securities $95.8M (down from $113.2M).
- Installed base 259 Saphyr systems (+47% YoY); 5,226 flowcells sold (+62% YoY).
- Cost reduction initiative targets ~$20M savings over 4–5 quarters, includes workforce reduction effective May 8, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000141169023000022/0001411690-23-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000141169023000022/bngo-20230509.htm
  HTML page:      https://secwatch.observer/filing/0001411690-23-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer